期刊文献+

小檗胺对肝癌SMMC-7721细胞侵袭转移的影响 被引量:2

Effect of Berbamine on Migration and Invasion of Human Liver Cancer SMMC-7721 Cells
原文传递
导出
摘要 目的研究小檗胺对人肝癌SMMC-7721细胞侵袭转移作用的影响及其可能的机制。方法在体外用不同浓度小檗胺处理肝癌SMMC-7721细胞,采用MTT法检测细胞活力的变化;采用细胞划痕试验、Transwell迁移和侵袭试验检测肿瘤细胞侵袭转移能力;采用Western blot法检测细胞上皮间质转化相关蛋白E-cadherin和Vimentin的表达。结果 MTT结果显示浓度<20mmol·L^(-1)的小檗胺对SMMC-7721细胞存活率无显著影响。划痕试验和Transwell结果显示,小檗胺呈浓度依赖性抑制肝癌SMMC-7721细胞迁移和侵袭过程。Westernblot结果表明,小檗胺显著增强SMMC-7721细胞中E-cadherin表达,而减弱Vimentin表达。结论人肝癌SMMC-7721细胞侵袭转移能力可被小檗胺抑制,其机制可能与其调控上皮间质转化相关蛋白的表达有关。 OBJECTIVE To study the effect and possible mechanism of berbamine on migration and invasion of human liver cancer SMMC-7721 cells.METHODS After SMMC-7721 cells were incubated with different concentration berbamine in vitro.The cell survival rate was assessed by MTT assay.The effect of berbamine on the migration and invasion of SMMC-7721 cells were detected by wound healing and transwell assays.The expression of E-cadherin and Vimentin protein involved in epithelial mesenchymal transition (EMT) was determined by Western blot assay.RESULTS MTT results showed berbamine exhibited no effect on SMMC-7721 cell survival rate in a range of concentrations.Both wound healing and transwell results showed that berbamine inhibited the migration and invasion of SMMC-7721 cells in a concentration-dependent manner.The Western blot assay confirmed that berbamine could decrease the expression of Vimentin,and increase the expression of E-cadherin.CONCLUSION Berbamine could influence the SMMC-7721 cells migration and invasion,which might be associated with the regulation of the expression of proteins involved in EMT.
作者 余彬彬 钱金娥 曹剑波 YU Binbin;QIAN Jin'e;CAO Jianbo(The Affliated Zhangjiagang Hospital of Sooehow University Department of Pharmacy,Suzhou 215600,China;The Affliated Zhangjiagang Hospital of Soochow University Center of Translational Medicine,Suzhou 215600,China)
出处 《中国现代应用药学》 CAS CSCD 北大核心 2018年第12期1771-1775,共5页 Chinese Journal of Modern Applied Pharmacy
基金 苏州市科技计划项目(SYSD2017160)
关键词 肝癌 小檗胺 SMMC-7721细胞 侵袭 转移 上皮间质转化 hepatocellular carcinoma berbamine SMMC-7721 cell migration invasion epithelial mesenchymal transition
  • 相关文献

参考文献4

二级参考文献38

  • 1董庆华,郑树,徐荣臻,吕庆华,何立明.小檗胺对多药耐药K562/Adr细胞作用的研究[J].中国中西医结合杂志,2004,24(9):820-822. 被引量:8
  • 2吴东,林茂芳,赵小英.小檗胺对K562细胞体外及体内作用的实验研究[J].中国实验血液学杂志,2005,13(3):373-378. 被引量:8
  • 3郭治彬,付金国.小檗胺的心血管药理作用研究进展[J].中国中西医结合杂志,2005,25(8):765-768. 被引量:16
  • 4郑作文,阎莉.藤茶双氢杨梅树皮素抗肝癌H_(22)的实验研究[J].中医药学刊,2006,24(9):1627-1629. 被引量:10
  • 5Nowell P, Hungerford D. A minute chromosome in human chronic granulocytic leukemia. Science 1960; 132: 1497.
  • 6KonopkaJB, Watanabe SM, Witte ON. An alteration of the human c-ABL protein in K562 leukemia-cells unmasks associated tyrosine kinase-activity. Cell 1984; 37: 1035-42.
  • 7Kirchner D, Duyster J, Ottmann O, Schmid RM, Bergmann L, Munzert G. Mechanisms ofbcr-Abl-mediated NF-kappa B/Re1 activation. Exp Hemato12003; 31 : 504-11.
  • 8Steelman LS, Pohnert SC, Shelton JG, Franklin RA, Bertrand FE, McCubreyJA. JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR- ABL in cell cycle progression and leukemogenesis. Leukemia 2004; 18: 189-218.
  • 9Druker BJ, Guilhot F, O'Brien SG, Gathmann I, Kantarjian H, Gattermann N, et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. New Engl J Med 2006; 355: 2408- 17.
  • 10Gorre ME, Mohammed M, Ellwood K, Hsu N, Paquette R, Rao PN, et al. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 2001; 293: 876-80.

共引文献32

同被引文献14

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部